Skip to content

Vaxcyte

US · PCVX #1630 by market cap Listed 2020
55.39 -2.97 -5.09%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 9 analysts

Buy
Avg price target 115.63 +108.8%
Price target rangecurrent 55.39
Low75.00
Avg115.63
High163.00
Buy 89% Hold 11% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-05 TD Cowen -- Buy 75.00
2026-11-05 BofA Securities -- Buy --
2026-11-04 BTIG -- Buy 89.00
2026-10-18 Guggenheim -- Buy 125.00
2026-10-12 Cantor Fitzgerald -- Buy 120.00
2026-10-06 Goldman Sachs -- Hold 85.00
2026-10-05 Mizuho Securities -- Buy 163.00
2026-10-05 BofA Securities -- Buy 146.00
2026-10-05 Jefferies -- Buy 146.00
2026-10-05 Needham -- Buy 122.00
2026-10-05 Guggenheim -- Buy 125.00
2026-09-28 BofA Securities -- Buy --
2026-09-25 Needham -- Buy 110.00
2026-08-06 Needham -- Buy 110.00
2026-08-05 TD Cowen -- Buy 75.00
2026-08-05 BofA Securities -- Buy 133.00
2026-08-05 Guggenheim -- Buy 116.00
2026-07-29 BTIG -- Buy 89.00
2026-06-26 Needham -- Buy 110.00
2026-06-18 Mizuho Securities -- Buy 163.00
2026-06-02 Mizuho Securities -- Buy 163.00
2026-05-21 Evercore -- Buy --
2026-05-07 BofA Securities -- Buy --
2026-05-07 Needham -- Buy 110.00
2026-05-06 TD Cowen -- Buy 75.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2025/Q4 2026-02-24 After close ±9.54% +2.75% (in line)
2024/Q4 2025-02-25 After close ±17.57% -0.88% (in line)
2023/Q4 2024-02-27 After close ±12.24% -7.33% (in line)
2022/Q4 2023-02-27 After close ±15.57% -3.14% (in line)
2021/Q4 2022-02-28 -- ±15.02% +2.52% (in line)
2020/Q4 2021-03-29 -- -- -4.34%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Vaxcyte discussion 0 comments

Add a comment